---
title: Buy Uloric (Febuxostat) 40mg, 80mg Pills Online
description: Uloric (Febuxostat) 40mg/80mg Pills is a trusted treatment for chronic gout management. Order from our secure online pharmacy for reliable delivery.
type: product
language: en 
url: https://medsforsale.net/buy-uloric-online-en
availability: in_stock
price_min: 41.99
price_max: 280.99
currency: USD
offers:
  - name: 40mg x 30 pills
    price: 41.99
  - name: 40mg x 60 pills
    price: 74.99
  - name: 40mg x 90 pills
    price: 102.99
  - name: 40mg x 120 pills
    price: 125.99
  - name: 40mg x 180 pills
    price: 179.99
  - name: 80mg x 30 pills
    price: 59.99
  - name: 80mg x 60 pills
    price: 111.99
  - name: 80mg x 90 pills
    price: 161.99
  - name: 80mg x 120 pills
    price: 203.99
  - name: 80mg x 180 pills
    price: 280.99
---

# Buy Uloric (Febuxostat) 40mg, 80mg Pills Online

Uloric, with the active ingredient Febuxostat, is a xanthine oxidase inhibitor developed by Takeda Pharmaceuticals. It is used to lower uric acid levels in adults with gout, helping to prevent the buildup of crystals that cause painful flare-ups. Unlike some older treatments, Uloric is highly targeted for long-term uric acid management. Our online store serves as a professional source for accessing Uloric in 40mg and 80mg pills with guaranteed quality.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **40mg** | 30 pills | **$41.99** | $1.40 | In Stock |
| **40mg** | 60 pills | **$74.99** | $1.25 | In Stock |
| **40mg** | 90 pills | **$102.99** | $1.14 | In Stock |
| **40mg** | 120 pills | **$125.99** | $1.05 | In Stock |
| **40mg** | 180 pills | **$179.99** | $1.00 | In Stock |
| **80mg** | 30 pills | **$59.99** | $2.00 | In Stock |
| **80mg** | 60 pills | **$111.99** | $1.87 | In Stock |
| **80mg** | 90 pills | **$161.99** | $1.80 | In Stock |
| **80mg** | 120 pills | **$203.99** | $1.70 | In Stock |
| **80mg** | 180 pills | **$280.99** | $1.56 | In Stock |


[Buy Now](https://medsforsale.net/buy-uloric-online-en)

## Introduction 

Uloric (febuxostat) is an oral medication indicated for the long-term management of hyperuricemia in adults with gout. It belongs to the class of xanthine oxidase inhibitors, which lower serum uric acid by blocking its production. The drug is supplied as a tablet in two strength options-40 mg and 80 mg. In addition to its primary role in gout, febuxostat has been investigated for several other conditions that involve elevated uric acid levels, although those uses are not currently approved by regulatory agencies.

---

## What is Uloric? 

Uloric is a prescription tablet containing the active ingredient febuxostat, a selective non-purine inhibitor of the enzyme xanthine oxidase. The medication was developed by Takeda Pharmaceutical Company and received U.S. FDA approval in 2009 for the treatment of chronic gout. While Uloric is the brand name under which febuxostat is marketed, the same molecule is also available from other manufacturers under different brand names and as a generic product. 

**Key facts** 

- **Active compound:** febuxostat 
- **Dosage forms:** film-coated tablets, 40 mg and 80 mg 
- **Therapeutic class:** xanthine oxidase inhibitor 
- **Manufacturer:** Takeda (Uloric); various licensed manufacturers for generic equivalents 

---

## How Uloric Works 

Febuxostat inhibits xanthine oxidase, the enzyme responsible for converting hypoxanthine and xanthine into uric acid. By reducing the enzymatic activity, febuxostat decreases the rate of uric acid production, leading to lower serum urate concentrations. The inhibition is competitive and reversible, with a high affinity for the molybdenum-pterin domain of the enzyme, which distinguishes it from earlier agents such as allopurinol. 

The therapeutic effect usually becomes evident within two weeks of daily dosing, with maximal serum urate reduction achieved after approximately six weeks of continuous therapy. Febuxostat is metabolized primarily by the liver (via glucuronidation and oxidation) and excreted in both urine and feces, allowing use in patients with varying degrees of renal impairment.

---

## Conditions Treated with Uloric 

- **Gout (chronic hyperuricemia)** - Uloric is approved to lower serum uric acid in adults with gout when allopurinol is not tolerated or does not achieve target urate levels. Lowering uric acid helps prevent crystal formation, reducing the frequency of gout flares and the progression of joint damage. 

- **Asymptomatic hyperuricemia** - In some jurisdictions, febuxostat may be prescribed for sustained uric acid elevations even without clinical gout, provided the clinician judges the benefit outweighs the risk. This indication is not universally approved and is applied at the physician’s discretion.

The drug’s efficacy in these conditions is supported by randomized controlled trials that demonstrated significant reductions in serum urate compared with placebo and allopurinol, as well as a decrease in gout flare rates when used as part of a comprehensive urate-lowering strategy.

---

## Off-Label and Investigational Uses of Uloric 

- **Chronic kidney disease (CKD) associated hyperuricemia** - Small-scale studies have reported that febuxostat may slow the decline of estimated glomerular filtration rate (eGFR) in patients with CKD and elevated urate. Evidence remains limited, and regulatory bodies have not approved febuxostat for CKD treatment. 

- **Cardiovascular risk reduction** - The CARES trial examined cardiovascular safety in patients with gout and found a higher incidence of cardiovascular mortality with febuxostat compared with allopurinol. Consequently, febuxostat is not approved for cardiovascular indication, and clinicians must weigh risks carefully. 

- **Tumor lysis syndrome prophylaxis** - Febuxostat’s potent urate-lowering effect has prompted investigation as an alternative to rasburicase in preventing uric acid nephropathy during aggressive chemotherapy. This application is experimental and should only be considered within controlled clinical protocols. 

- **Prevention of uric acid kidney stones** - Some case series suggest that maintaining low serum uric acid may reduce recurrence of uric acid calculi. This use remains off-label and lacks robust trial data. 

**Important:** Off-label use of febuxostat must be supervised by a qualified healthcare provider. The safety and efficacy for these indications have not undergone the full regulatory review required for approved uses.

---

## Is Uloric the Right Medication for You? 

Uloric is appropriate for adults who: 

- Have a confirmed diagnosis of gout and require long-term urate-lowering therapy. 
- Have demonstrated intolerance or inadequate response to allopurinol (e.g., hypersensitivity, persistent hyperuricemia). 
- Possess mild to moderate renal impairment (eGFR ≥30 mL/min/1.73 m²), as febuxostat does not require dose adjustment in most cases of renal dysfunction. 

Uloric may be unsuitable for patients with: 

- Severe hepatic impairment (Child-Pugh Class C). 
- Known hypersensitivity to febuxostat or any tablet excipients. 
- History of cardiovascular events where the risk-benefit profile is unfavorable. 

A thorough clinical assessment-including liver function tests, cardiovascular evaluation, and review of concomitant medications-is essential before initiating therapy.

---

## Risks, Side Effects, and Interactions 

### Common 

- **Elevated liver enzymes** - Transient increases in ALT/AST are seen in 5-10 % of patients. Routine monitoring is recommended. 
- **Rash or pruritus** - Mild skin reactions occur in up to 8 % of users. 
- **Gastrointestinal discomfort** - Nausea, diarrhea, or dyspepsia may affect 5-7 % of patients, usually early in treatment. 

### Rare 

- **Severe hypersensitivity reactions** - Including Stevens-Johnson syndrome or toxic epidermal necrolysis; incidence <0.1 %. 
- **Myocardial infarction** - Case reports describe ischemic events, though causality is uncertain. 

### Serious 

- **Hepatotoxicity** - Clinically significant hepatitis requiring drug discontinuation has been reported; obtain baseline and periodic liver function tests. 
- **Severe cardiovascular events** - The CARES trial identified higher rates of cardiovascular death in patients with established heart disease; avoid febuxostat in high-risk individuals unless no alternatives exist. 
- **Agranulocytosis** - Extremely rare but life-threatening drop in neutrophil count; monitor complete blood count if clinically indicated. 

#### Drug-Drug Interactions 

- **Azathioprine / Mercaptopurine** - Febuxostat may increase plasma concentrations, raising toxicity risk; dose adjustments or alternative urate-lowering agents should be considered. 
- **Warfarin** - Potential for increased INR; more frequent coagulation monitoring is advised. 
- **Rifampin** - Induces hepatic enzymes and may lower febuxostat levels, reducing efficacy. 

#### Drug-Food Interactions 

- **Alcohol** - Excessive intake can elevate uric acid and exacerbate gout; patients should limit alcohol while on febuxostat. 
- **High-purine meals** - Do not negate the drug’s effect, but dietary moderation supports optimal urate control. 

---

## Use: Dosing, Missed Dose, Overdose 

- **Initial dosing** - Most adults start with 40 mg once daily. The dose may be increased to 80 mg after two weeks if serum urate remains above target (<6 mg/dL). 
- **Renal impairment** - No dose reduction is required for eGFR ≥30 mL/min/1.73 m². For eGFR <30, use with caution and consider specialist advice. 
- **Missed dose** - Take the missed tablet as soon as remembered on the same day. Do not double the dose the following day. 
- **Overdose** - Symptoms may include nausea, vomiting, dizziness, and severe liver dysfunction. Immediate medical evaluation is required; supportive care is the mainstay of treatment. 
- **Administration considerations** - Tablets may be taken with or without food. Avoid concomitant use of strong CYP3A4 inducers without consulting a health professional. Driving or operating machinery is safe once the individual confirms that dizziness or fatigue are not present. 

---

## FAQ 

- **What is the difference between febuxostat and allopurinol?** 
 Febuxostat selectively inhibits xanthine oxidase with higher potency and does not require dose reduction in most cases of renal impairment, whereas allopurinol may need adjustment and carries a risk of hypersensitivity syndrome. 

- **Can I travel internationally with Uloric tablets?** 
 Yes, but keep the medication in its original packaging with a copy of the prescription (or a doctor’s letter) to satisfy customs regulations in many countries. 

- **Does febuxostat interact with over-the-counter pain relievers?** 
 Non-steroidal anti-inflammatory drugs (NSAIDs) do not have a direct pharmacokinetic interaction with febuxostat, but combined use may increase the risk of gastrointestinal irritation. 

- **How long does it take for serum uric acid to reach a stable level?** 
 Steady-state urate reduction is typically observed after six weeks of consistent dosing, though some patients may achieve target levels earlier. 

- **Are there any special storage requirements for Uloric tablets?** 
 Store at room temperature (20-25 °C/68-77 °F) away from excess heat, moisture, and direct sunlight. Do not refrigerate. 

- **Will febuxostat cause weight gain?** 
 Weight change is not a recognized side effect; however, improved gout control may enable increased physical activity, indirectly influencing weight. 

- **Can I take Uloric if I have hepatitis C?** 
 Febuxostat is metabolized in the liver, and existing hepatic disease may increase the risk of liver enzyme elevation. Close monitoring is advised, and alternative therapies may be preferred. 

- **Is there a need for regular blood tests while on Uloric?** 
 Baseline liver function tests are recommended, with repeat testing after 2-4 weeks and periodically thereafter. Monitoring renal function is also prudent in patients with pre-existing kidney disease. 

- **What should I do if I experience a rash while taking Uloric?** 
 Mild rashes may resolve without discontinuation, but any skin reaction that spreads, becomes painful, or is accompanied by fever warrants immediate medical assessment. 

- **Does febuxostat affect uric acid levels in urine?** 
 Yes, by decreasing uric acid production, febuxostat reduces urinary uric acid excretion, which may lower the risk of uric acid stone formation. 

- **Can I use Uloric together with a low-purine diet?** 
 Combining pharmacologic urate-lowering therapy with dietary modifications provides synergistic control and is encouraged for optimal gout management. 

- **Is febuxostat safe for patients on dialysis?** 
 Limited data exist for patients on chronic hemodialysis; dosing should be individualized and conducted under specialist supervision. 

---

## Glossary 

**Xanthine oxidase** 
: An enzyme that catalyzes the final steps of purine degradation, converting hypoxanthine to xanthine and xanthine to uric acid. 

**Serum urate (uric acid) level** 
: The concentration of uric acid in the blood, typically measured in mg/dL; elevated levels predispose to gout crystal formation. 

**Pharmacokinetics** 
: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body. 

**Steady-state** 
: The condition in which the overall intake of a drug equals its elimination, resulting in constant plasma concentration. 

---

## Buying Uloric from [our online pharmacy](https://medsforsale.net/buy-uloric-online-en) 

Uloric can be obtained securely through **[our online pharmacy](https://medsforsale.net/buy-uloric-online-en)**. We source the medication from licensed, audited suppliers that meet international quality standards, ensuring that each tablet matches the manufacturer’s specification. Our pricing model targets near-manufacturer cost, which helps reduce the financial burden for patients who may not have insurance coverage or who encounter high out-of-pocket charges at local pharmacies. 

Key benefits include: 

- **Affordability:** Competitive pricing without compromising quality. 
- **Verified authenticity:** All batches are quality-checked and come with a full chain-of-custody record. 
- **Discreet delivery:** Packages are sealed in unmarked containers and shipped via reliable carriers, with typical express delivery in 7 days and regular airmail arriving within 3 weeks. 
- **Privacy-focused service:** As a pharmacy broker, we partner with overseas licensed pharmacies, allowing us to maintain strict confidentiality while providing access to medications that may be limited domestically. 

Patients seeking a cost-effective, trustworthy source for Uloric can rely on this service to obtain their medication safely and privately.

---

## Disclaimer 

The information provided about **Uloric** is intended for general educational purposes only and does not replace professional medical consultation. All treatment decisions, including those concerning off-label use, should be made under the supervision of a qualified healthcare provider. Readers are presumed to be responsible adults capable of making informed health choices. [our online pharmacy](https://medsforsale.net/buy-uloric-online-en) offers access to **Uloric** for individuals who may encounter limited availability through traditional pharmacies, prescription-based insurance programs, or who are searching for affordable generic alternatives. Always consult your doctor before initiating, modifying, or discontinuing any medication.